3rd Circ. Told Actavis Allows Noncash Settlement Scrutiny
A Third Circuit panel was urged during oral arguments on Wednesday to find that a patent settlement between GlaxoSmithKline LLC and Teva Pharmaceutical Industries Ltd. postponing production of a generic epilepsy...To view the full article, register now.
Already a subscriber? Click here to view full article